News Focus
News Focus
Followers 2
Posts 927
Boards Moderated 0
Alias Born 09/27/2005

Re: opportunityknocking post# 27580

Friday, 11/05/2010 5:54:51 PM

Friday, November 05, 2010 5:54:51 PM

Post# of 30387
I know one person that is not a happy camper after that press release. LOL
So you can sleep tonite: BioCurex is a leading edge biotechnology company with proprietary and patented technologies in the areas of cancer diagnosis, imaging and therapy. The Company has developed a blood test that detects 90% of all cancers based on the cancer marker, RECAF™. The RECAF test has a high sensitivity and specificity for breast and lung cancers, which are two of the most common and deadly cancers. There are no comparable cancer markers available for detection of early stages of breast and prostate cancer. BioCurex has indicated that RECAF detects cancer with higher sensitivity/specificity than
mammograms or colonoscopies.

Time to go fishing. Play nice!

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today